99
Views
12
CrossRef citations to date
0
Altmetric
Research Article

CAS Enhances Chemotherapeutic Drug-Induced p53 Accumulation and Apoptosis: Use of CAS for High-Sensitivity Anticancer Drug Screening

, , , , &
Pages 771-776 | Received 25 Jun 2008, Accepted 24 Aug 2008, Published online: 02 Dec 2008

REFERENCES

  • P. Behrens, U. Brinkmann, and A. Wellmann. 2003. CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 8:39–44.
  • U. Brinkmann, E. Brinkmann, M. Gallo, U. Scherf, and I. Pastan. 1996. Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry 35:6891–6899.
  • M. Iwamoto, S. Yoshida, and S. Hirose. 1984. Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography. J. Chromatogr. 310:151–157.
  • M. F. Izaguirre, M. N. Vergara, and V. H. Casco. 2006. CAS role in the brain apoptosis of Bufo arenarum induced by cypermethrin. Biocell 30:309–320.
  • S. Jacob, B. S. Kaphalia, N. Jacob, and A. E. Ahmed. 2006. The water disinfectant byproduct dibromoacetonitrile induces apoptosis in rat intestinal epithelial cells: possible role of redox imbalance. Toxicol. Mech. Meth. 16:227–234.
  • M. C. Jiang, S. F. Luo, L. T. Li, C. C. Lin, S. Y. Du, C. Y. Lin, Y. W. Hsu, and C. F. Liao. 2007. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells. J. Exp. Clin. Cancer Res. 26:91–99.
  • C. F. Liao, S. F. Luo, L. T. Li, C. Y. Lin, Y. C. Chen, and M. C. Jiang. 2008a. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J. Exp. Clin. Cancer Res. 27:15. doi: 10.1186/1756-9966-27-15
  • C. F. Liao, S. F. Luo, T. Y. Shen, C. H. Lin, J. T. Chien, S. Y. Du, and M. C. Jiang. 2008b. CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB Rep. 41:210–216.
  • H. Lövborg, J. Gullbo, and R. Larsson. 2005. Screening for apoptosis-classical and emerging techniques. Anticancer Drugs 16:593–599.
  • J. Moriquand, M. H. Bartoli, M. A. Mermet, J. C. Stage, and C. L. Moriquand. 1985. Determination of hormoneresponsive breast tumor cells by tamoxifen induced fluorescence. Pathologica 77:273–279.
  • R. N. Pierce, and P. I. Jatlow. 1979. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. J. Chromatogr. 164:471–478.
  • S. K. Ramaiah, and H. Jaeschke. 2007. Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol. Mech. Meth. 17:431–440.
  • A. M. Sharifi, and S. H. Mousavi. 2008. Studying the effects of lead on DNA fragmentation and proapoptotic Bax and antiapoptotic Bcl-2 protein expression in PC12 cells. Toxicol. Mech. Meth. 18:75–79.
  • M. Sharma, R. Jain, E. Ionescu, and H. K. Slocum. 1995. Capillary electrophoretic separation and laser-induced fluorescence detection of the major DNA adducts of cisplatin and carboplatin. Anal. Biochem. 228:307–311.
  • R. H. Shoemaker, D. A. Scudiero, G. Melillo, M. J. Currens, A. P. Monks, A. A. Rabow, D. G. Covell, and E. A. Sausville. 2002. Application of high-throughput, molecular-targeted screening to anticancer drug discovery. Curr. Top. Med. Chem. 2:229–246.
  • A. K. Singh, Y. Yin Jiang, and S. Gupta. 2007. Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation. Toxicol. Mech. Meth. 17:331–347.
  • A. Stankiewicz, and E. Skrzydlewska. 2006. Amifostine-antioxidant drug in anticancer therapy. Toxicol. Mech. Meth. 16:181–188.
  • C. S. Tsai, S. F. Luo, C. C. Ning, C. L. Lin, M. C. Jiang, and C. F. Liao. 2008. Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F2α. Biomed. Pharmacother. (2008). doi: 10.1016/j.biopha.2008.07.09
  • S. Wang, and W. S. El-Deiry. 2004. The p53 pathway: targets for the development of novel cancer therapeutics. Cancer Treat. Res. 119:175–187.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.